Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-(((4-((2-fluorophenyl)methoxy)phenyl)methyl)amino)propanamide
2. Ralfinamide
1. Ralfinamide
2. 133865-88-0
3. (s)-2-((4-((2-fluorobenzyl)oxy)benzyl)amino)propanamide
4. Priralfinamide [inn]
5. Nw-1029
6. (2s)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide
7. (2s)-2-(4-(2-fluorobenzyloxy)benzylamino)propanamide
8. 3lpf0s0gvv
9. Ralfinamida
10. Pnu-0154339e
11. Fce-26742a
12. Ralfinamida [inn-spanish]
13. Unii-3lpf0s0gvv
14. (s)-2-(4-(2-fluorobenzyloxy)benzylamino)propanamide
15. (s)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide
16. (s)-2-[[4-[(2-fluorobenzyl)oxy]benzyl]amino]propanamide
17. Schembl67328
18. Chembl2107771
19. Dtxsid70158406
20. Bdbm161094
21. Mfcd08272558
22. Zinc72190123
23. Akos016006629
24. Db06649
25. Ncgc00370789-01
26. Ds-18607
27. Hy-101437
28. Cs-0021330
29. F12108
30. A888008
31. (s)-2-[4-(2-fluorobenzyloxy) Benzylamino]propanamide
32. Q21098885
33. (s)-2-[[4-(2-fluorobenzyloxy)benzyl]amino]propanamide
34. 2-(((4-((2-fluorophenyl)methoxy)phenyl)methyl)amino)propanamide
35. Us9051240, (s)-(+)-2-[4-(2-fluorobenzyloxy)-benzylamino]-propanamide
| Molecular Weight | 302.34 g/mol |
|---|---|
| Molecular Formula | C17H19FN2O2 |
| XLogP3 | 2.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 7 |
| Exact Mass | 302.14305602 g/mol |
| Monoisotopic Mass | 302.14305602 g/mol |
| Topological Polar Surface Area | 64.4 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 346 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in pain (acute or chronic).
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
42
PharmaCompass offers a list of Ralfinamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ralfinamide manufacturer or Ralfinamide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ralfinamide manufacturer or Ralfinamide supplier.
PharmaCompass also assists you with knowing the Ralfinamide API Price utilized in the formulation of products. Ralfinamide API Price is not always fixed or binding as the Ralfinamide Price is obtained through a variety of data sources. The Ralfinamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Priralfinamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Priralfinamide, including repackagers and relabelers. The FDA regulates Priralfinamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Priralfinamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Priralfinamide supplier is an individual or a company that provides Priralfinamide active pharmaceutical ingredient (API) or Priralfinamide finished formulations upon request. The Priralfinamide suppliers may include Priralfinamide API manufacturers, exporters, distributors and traders.
Priralfinamide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Priralfinamide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Priralfinamide GMP manufacturer or Priralfinamide GMP API supplier for your needs.
A Priralfinamide CoA (Certificate of Analysis) is a formal document that attests to Priralfinamide's compliance with Priralfinamide specifications and serves as a tool for batch-level quality control.
Priralfinamide CoA mostly includes findings from lab analyses of a specific batch. For each Priralfinamide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Priralfinamide may be tested according to a variety of international standards, such as European Pharmacopoeia (Priralfinamide EP), Priralfinamide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Priralfinamide USP).
